Pindolol, a beta-blocker, showed minimal impact on lipid metabolism in hypertensive patients over twelve months. Unlike other beta-blockers, it maintained stable triglycerides and fatty acids, with a significant increase in HDL-cholesterol ratio.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: